Open Access 01-09-2011 Review
Published in:
Abstract
Myostatin is an extracellular cytokine mostly expressed in skeletal muscles and known to play a crucial role in the negative regulation of muscle mass. Upon the binding to activin type IIB receptor, myostatin can initiate several different signalling cascades resulting in the upregulation of the atrogenes and downregulation of the important for myogenesis genes. Muscle size is regulated via a complex interplay of myostatin signalling with the insulin-like growth factor 1/phosphatidylinositol 3-kinase/Akt pathway responsible for increase in protein synthesis in muscle. Therefore, the regulation of muscle weight is a process in which myostatin plays a central role but the mechanism of its action and signalling cascades are not fully understood. Myostatin upregulation was observed in the pathogenesis of muscle wasting during cachexia associated with different diseases (i.e. cancer, heart failure, HIV). Characterisation of myostatin signalling is therefore a perspective direction in the treatment development for cachexia. The current review covers the present knowledge about myostatin signalling pathways leading to muscle wasting and the state of therapy approaches via the regulation of myostatin and/or its downstream targets in cachexia.
Metadata Literature
Title The role of myostatin in muscle wasting: an overview
Authors Yulia Elkina Stephan von Haehling Stefan D. Anker Jochen Springer
Publication date 01-09-2011
This content is only visible if you are logged in and have the appropriate permissions. Image Credits
Close-up of pink microscopic bacteria cells, X-ray of hand with arthritis at multiple joints/© stockdevil / Getty Images / iStock